Travelan is made using bovine colostrum from dairy cows which are immunised with a vaccine to produce high levels of enterotoxigenic E coli antibodies. Travelan works by binding to E coli bacteria and effectively prohibiting it from attaching to the intestinal tract and causing travellers’ diarrhoea. The specific antibodies bind to all the E coli serotypes and are not absorbed into the blood. Evedential proof of the tablets’ ability to reduce the risk of travellers diarrhoea is found in recent randomised, double blind placebo trials conducted in Europe and the US. The trials found that Travelan demonstrated protection of up to 90% aginst E coli infection. The trials also found Travelan had no reported side effects and that it also reduced the symptoms of gastrointestinal disorders such as abdominal cramps and stomach pain.
RRP: $22.95 Stockist: www.travelan.com.au.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jun 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jun 11
NEW data from the Australian Institute of Health and Welfare has revealed around 43% (or 8.5 million) of Australians aged 16-85 have experienced a mental disorder at some point in their lives.
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.